ESMO Recommendations on clinical reporting of genomics test results for solid cancers

(5:58)

ESMO Recommendations for Use of Tumour Multigene NGS in Metastatic Cancers

(5:49)

The ESMO Guidelines On Salivary Gland Cancers With Prof. Carla van Herpen | SGC UK

(15:29)

COVID-19 and cancer: the ESMO recommendations for clinical practice

(2:30)

ESMO 2024 Oncologists Burnout Insights

(2:51)

Updates to the ESMO clinical practice guidelines for CLL

(2:19)

ESMO OncologyPRO - Intro by Dr. E. SMYTH

(1:46)

ESCAT - How to classify genomic alterations according level of actionability

(4:22)

ESMO Vision stories of Specialised Education: Elizabeth Smyth, ESMO Guidelines author

(1:48)

10 interventions against all cancers - how they work! (#163)

(22:59)

ESICM Guidelines 2023 on ARDS: Definition

(2:39:57)

ESICM Guidelines for ARDS 2023

(19:59)

What Are the Best Choices for Getting Hydrated? | Educational Video | Layne Norton Phd

(8:53)

Next Generation Sequencing for Patients with Advanced Cancers | ESMO PMWG Recommendations 2024

(12:57)

ESMO 2024: Highlights and analysis

(24:35)

HCC Staging

(1:12:46)

How I use Todoist To #GetWorkDone - My Todoist Setup!

(6:11)

\

(1:29:29)

ESMO 2024: Lower GI cancer update

(8:2)

MAP 2024: shaping the future of precision oncology

(1:45)

ESMO Clinical Practice Guidelines: beyond EGFR and ALK

(2:47)

Recommendations for the use of NGS in patients with metastatic cancer

(4:2)

Key updates and changes to the ESMO clinical practice guidelines for CLL

(1:29)

ASCO 2024 and ESMO GI 2024 Updates Webinar | Feat. Dr. Samuel Klempner

(1:3:54)

#MAP2020: Tumour profiling and precision oncology - don’t fear the germline

(3:51)

Controversy Debate 4: Treatment algorithms in metastatic CRC - ESMO guidelines

(19:52)

2024 Metastatic Urothelial Carcinoma Guidelines: NCCN, EAU, ESMO

(26:18)

ESMO Vision stories of Specialised Education: Silke Gillessen, ESMO Guidelines Committee member

(2:4)

ESO-ESMO-ABC guidelines in metastatic breast cancer

(9:26)

ESMO Guidelines Provide Clear Blueprint for Managing Immunotherapy Toxicities

(6:55)